{"doi":"10.1111/ejn.16061","title":"Profiles of women in science: Illana Gozes, Professor Emerita of Clinical Biochemistry, Tel Aviv University","abstract":"We at EJN are proud to introduce Dr. Illana Gozes as the next scientist for our series of Women in Neuroscience. We began this series to bring visibility and recognition to the superb women scientists working in our community (Helmreich et al., 2017) (you can find all of the previous profiles at https://onlinelibrary.wiley.com/doi/toc/10.1111/(ISSN)1460-9568.women-in-science). Dr. Gozes is currently a Professor Emerita of Clinical Biochemistry, serving as the Director of the Elton Laboratory for Molecular Neuroendocrinology at the Department of Human Molecular Genetics and Biochemistry, Faculty of Medicine, Sagol School of Neuroscience, and the Adams Super Center for Brain Studies at Tel Aviv University. At Doug Brenneman Lab, NIH Receiving the Teva Prize in 1993 With Ph.D. mentor, Dr. Uri Littauer Dr. Gozes earned a BSc at Tel Aviv University (1973) and a Ph.D. at Weizmann Institute of Science in 1978, completed postdocs at MIT (1979–1980) and the Salk Institute (1981–1982) and was a senior scientist and associate professor at the Weizmann (1982–1988) and a visiting scientist (1989–1990) and later a Fogarty-Scholar-in-Residence at NIH (1995–1996). In 1990, Dr. Gozes became an associate professor (full professor, 1993) at Tel-Aviv University and received her endowed professorial chair in 1997 (Lily and Avraham Gildor Chair for the Investigation of Growth Factors), which she held until 2019. In 2004, her laboratory was endowed and renamed as the Dr. Diana and Ziga (Zelman) Elton (Elbaum) Laboratory for Molecular Neuroendocrinology. For about a decade, she was in charge of the Adams Super Center for Brain Studies at Tel Aviv University, overseeing university-wide brain research, and she also served as the President of the Israel Society for Neuroscience. She further served on the Israel Council for Higher Education (2016–2022). Currently, she is directing the Israeli Brain Bee Competition, serving as the Secretary of the European Society for Neurochemistry, an Israeli Ambassador to ERA-NET Neuron, a Regional Editor for the Journal of Alzheimer's Disease, a member of the Scientific Advisory Board of the Alzheimer's Association of Israel, the President of the Summer Neuropeptide Meeting and is Editor-in-Chief of the Journal of Molecular Neuroscience. A brief description of her research: Neuronal Plasticity and Nerve Cell Protection in Disease The Gozes lab takes a multi-level approach to the study of brain function, behavior, memory, and drug discovery, from molecules to cures. Targeting autism and schizophrenia as well as Alzheimer's disease and related neurodegeneration and utilizing a multidisciplinary approach, the lab investigates different aspects of neuronal plasticity and nerve cell protection, at the molecular, cellular, and systems levels. A major focus in the laboratory is on nerve structure and transport mechanisms. Professor Gozes discovered ADNP (Activity-Dependent Neuroprotective Protein), an essential protein for brain formation implicated in autism, schizophrenia, Alzheimer's disease, and cancer. She further discovered the drug candidate davunetide, a short fragment of the large ADNP molecule also named NAP (NAPVSIPQ), CP201 and AL-108. Her most recent findings are delineated in her recent EJN publication entitled: “A novel davunetide (NAPVSIPQQ to NAPVSIPQE) point mutation in ADNP causes a mild developmental syndrome” (Gozes & Shazman, 2023). EJN: I had the pleasure of speaking with Prof. Gozes in September 2022. A memorable quote: “We go into science not only to work on the birds and the bees, but we do want to do something that will be meaningful for humans for centuries.” What was the start of your journey to become a neuroscientist? Dr. Gozes: I was born and raised in Jerusalem. Life was centered around the Hebrew University, and the academic life was the best that you could get. There were many people in my life who were affiliated with the Hebrew University, so I knew firsthand what it meant to be a researc","journal":"European Journal of Neuroscience","year":2023,"id":379708,"datarank":0.0,"base_score":0.0,"endowment":0.0,"self_citation_contribution":0.0,"citation_network_contribution":0.0,"self_endowment_contribution":0.0,"citer_contribution":0.0,"corpus_percentile":null,"corpus_rank":null,"citation_count":1,"citer_count":0,"citers_with_citation_signal":0,"citers_with_endowment":0,"datacite_reuse_total":0,"is_dataset":false,"is_dataset_confidence":0.9114,"is_data_producer":false,"deposit_databanks":null,"is_oa":true,"file_count":0,"downloads":0,"has_version_chain":false,"published_date":"2023-01-01","fair_score":null,"fair_percentile":null,"algorithm_id":"datarank_citation_only_1hop_v6","ranking_scope":"data_only","authors":[{"id":1144391,"name":"Dana L. Helmreich","orcid":"0000-0003-1394-2577","position":0,"is_corresponding":true}],"reference_count":25,"raw_metadata":null,"created_at":"2026-07-19T01:16:56.650289Z","pmid":"37381605","pmcid":null,"fwci":null,"citation_percentile":null,"influential_citations":0,"oa_status":null,"license":null,"views":0,"total_file_size_bytes":0,"version_count":0,"fair_f":null,"fair_a":null,"fair_i":null,"fair_r":null,"fair_zscore":null,"fair_rationale":null,"fair_model":null,"fair_agent_version":null,"fair_fulltext_source":null,"fair_has_llm":null,"fair_computed_at":null,"clinical_trials":[],"software_tools":[],"db_accessions":[],"linked_datasets":[],"topics":[]}